Stock comparison
Lennox International
Strata Critical Medical
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LII
Lennox International
Market cap
$16.87B
Sector
Industrials
SRTA
Strata Critical Medical
Market cap
$530.41M
Sector
Industrials
Overall winner
Lennox International LII
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LII | SRTA | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 31F | LII |
| Benjamin Graham | 75B | 33F | LII |
| Philip Fisher | 56C | 45D | LII |
| Peter Lynch | 53C | 74C | SRTA |
| Joel Greenblatt | 53C | 27F | LII |
| Charlie Munger | 64C | 40D | LII |
| Terry Smith | 56C | 37D | LII |
Side-by-side metrics
| Metric | LII | SRTA |
|---|---|---|
| Market cap | $16.87B | $530.41M |
| P/E (TTM) | 22.2x | 8.8x |
| EV/EBIT | 19.0x | - |
| ROIC (TTM) | 23.93% | -4.92% |
| Gross margin | 33.06% | 20.52% |
| Net margin | 14.89% | 19.97% |
| Revenue CAGR 5y | 5.5% | 40.55% |
| EPS CAGR 5y | 15.65% | - |
| Debt / Equity | 1.6x | 0.0x |
| Dividend yield | 1.04% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LII leads on
- ROIC (TTM)23.93%vs -4.92%+121%
- Dividend yield1.04%vs 0.0%+100%
- Market cap$16.87Bvs $530.41M+97%
- Gross margin33.06%vs 20.52%+38%
SRTA leads on
- EV/EBIT-vs 19.0x+147%
- Debt / Equity0.0xvs 1.6x+99%
- Revenue CAGR 5y40.55%vs 5.5%+86%
- P/E (TTM)8.8xvs 22.2x+61%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.